Chubb Limited (CB) Stock Price & How to Invest

Chubb Limited is a global insurance company headquartered in Zurich, Switzerland, and one of the largest publicly traded property and casualty (P&C) insurers in the world. It underwrites commercial and personal P&C insurance, accident and health coverage, reinsurance, and life insurance across roughly 54 countries, serving multinational corporations, businesses, and individuals. Its scale and worldwide network let it service large multinational accounts that smaller carriers cannot, which acts as a competitive barrier. The company is widely regarded for underwriting discipline, meaning it prioritizes writing profitable policies over chasing premium volume.

The investment picture centers on consistent underwriting profitability, growing investment income from its large bond portfolio, and reliable capital returns. In 2025 Chubb reported record full-year net income of ~$10.31 billion and a record P&C combined ratio, and it has raised its dividend for over 30 consecutive years. A combined ratio below 100 percent means the core insurance business is profitable before investment income, and Chubb consistently runs in the low-to-mid 80s. The trade-off is that as a mature, large-cap insurer, growth tends to be steady rather than explosive, and results can be pressured in years with heavy catastrophe losses.

As a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year. Reserve adequacy is an ongoing risk, since claims can develop worse than initially estimated, especially in long-tail casualty lines. A large investment portfolio means results are sensitive to interest rates, credit spreads, and equity markets. Competitive pricing cycles (soft markets) can pressure premium growth and underwriting profitability. Because it operates globally, Chubb also carries foreign-exchange and geopolitical exposure across many jurisdictions.

23 analysts publish price targets on CB, averaging $365.26 against a $350.68 price as of August 2026, or +4.2%. The published targets run from $306.00 to $425.00, a moderate spread, and the ratings split 9 buy, 13 hold, 3 sell. Over the last six months there have been 10 raises and 1 cut among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CB forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Chubb Limited. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Underwriting discipline and margins. Chubb has repeatedly posted a P&C combined ratio in the low-to-mid 80s, among the best of large global insurers. The most optimistic published target, $425.00, assumes this works close to its best case.

The case against. As a P&C insurer, Chubb is exposed to large catastrophe losses from hurricanes, wildfires, earthquakes, and other severe events, which can compress margins in a bad year. The most pessimistic target, $306.00, is roughly what CB is worth if this bites instead.

Read the full bull and bear case on CB, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Chubb Limited's investor relations page or your broker.

• Revenue (FY2025): ~$59.6 billion
• Net income (FY2025): ~$10.31 billion
• Diluted EPS (FY2025): ~$25.68
• Market cap: ~$124 billion
• Trailing P/E: ~12.8x
• Annual dividend: ~$4.08 per share

Chubb reported record full-year 2025 net income of ~$10.31 billion (up ~11 percent) on revenue of ~$59.6 billion, with a record P&C combined ratio. The stock trades around ~12 to 13 times trailing earnings, a valuation broadly in line with large P&C peers. First-quarter 2026 net income was ~$2.32 billion, or ~$5.88 per share, benefiting from strong underwriting and investment income.

These are the investment theses CB naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to CB: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CB exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so CB sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CB fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Chubb is a scale global P&C insurer that pairs consistent underwriting profitability with steady capital returns, making it a quality-and-durability holding in the insurance space.

Whether CB is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CB a buy or a sell?, and where the stock could go from here in the CB stock forecast.

For income investors, whether CB pays a dividend and how the payout looks is covered in does CB pay a dividend? And to weigh CB against a peer, read the full side-by-side comparisons: CB vs AXP and CB vs BAC.